CDC: Cases of Vaping-Linked Lung Illness Rise to 530 Across 38 States
FDA currently analyzing more than 150 vaping product samples tied to these cases
Respiratory Diseases/Disorders
Vaping-Linked Lung Illness Claims Seventh Victim
According to CDC, 380 people in 36 states have come down with the vaping-related sickness
Selpercatinib Promising in RET Fusion-Positive NSCLC
Treatment with selpercatinib (LOXO-292) was associated with high objective response rate (ORR) in heavily pretreated patients with RET fusion-positive non-small cell lung cancer (NSCLC), according to research presented at the IASLC 2019 World Conference on Lung Cancer. Researchers from Memorial Sloan Kettering Cancer Center presented data from the LIBRETTO-001 (LOXO-292 Investigated to Block RETaltered Tumors)…
FDA Warns of Possible Interstitial Lung Disease, Pneumonitis With Certain Breast Cancer Drugs
Healthcare professionals are being advised to monitor patients regularly for pulmonary symptoms indicative of ILD and/or pneumonitis, including hypoxia, cough, dyspnea, and interstitial infiltrates on radiologic exams.
Nucala Approved for Younger Patients With Severe Eosinophilic Asthma
The product is available in 100mg single-dose vials for reconstitution and in 100mg/mL single-dose prefilled autoinjectors and glass syringes.
AMA: Do Not Use Electronic Cigarettes
AMA statement comes as sixth death from vaping-related lung illness confirmed
Studies Look at E-Cigarette Use Linked to Pulmonary Illness
Persons should consider not using e-cigarettes while investigation is ongoing and cause is uncertain
FDA Approves Treatment for Systemic Sclerosis-Associated Interstitial Lung Disease
The Food and Drug Administration (FDA) has approved Ofev (nintedanib; Boehringer Ingelheim) capsules as the first FDA-approved treatment to slow the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD). The approval was based on results from the 52-week, randomized, double-blind, placebo-controlled phase 3 SENSCIS trial that evaluated the…
ATS Guideline Outlines Lab Tests for Diagnosis of Fungal Infections
Guideline addresses lab testing for diagnosis of fungal infections in pulmonary medicine, critical care
Investigational Vaccine to Prevent RSV in Older Patients Gets Breakthrough Status
Janssen announced that the Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for their investigational prophylactic vaccine for the prevention of respiratory syncytial virus (RSV)-mediated lower respiratory tract disease in adults aged 60 years and older. RSV is a highly prevalent and contagious respiratory infection. It is the most common cause of bronchitis…
